IQVIA
Erkan Su is a seasoned professional in the pharmaceutical and clinical research fields, currently serving as a Senior Global Trial Manager at IQVIA since June 2025. Prior experience includes a role as Senior Manager for Post-Marketing Requirements Studies at argenx and Global Clinical Trial Manager (Late Phase) at Gilead Sciences, with tenure at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Senior Site Manager. Previous positions span various notable organizations such as Bayer HealthCare, Sanofi, and Aventis Pharma, where Erkan held titles including Medical Affairs Studies Manager, Clinical Project Leader, and Drug Specialist-Oncology. Educational credentials include a Master of Science in Biochemistry and a Bachelor of Science in Biology, both obtained from Orta Doğu Teknik Üniversitesi.
This person is not in any teams
This person is not in any offices
IQVIA
164 followers
IQVIA, formerly Quintiles IMS Holdings, Inc., is an American multinational company serving the combined industries of health information technologies and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.